Literature DB >> 1757469

Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines.

T M Nguyen1, J M Ellis, D R Love, K E Davies, K C Gatter, G Dickson, G E Morris.   

Abstract

mAbs have been raised against different epitopes on the protein product of the DMDL gene, which is an autosomal homologue of the X-linked DMD gene for dystrophin. These antibodies provide direct evidence that DMDL protein is localized near acetylcholine receptors at neuromuscular junctions in normal and mdx mouse intercostal muscle. The primary location in tissues other than skeletal muscle is smooth muscle, especially in the vascular system, which may account for the wide tissue distribution previously demonstrated by Western blotting. The DMDL protein was undetectable in the nonjunctional sarcolemma of normal human muscle, but was observed in nonjunctional sarcolemma of Duchenne muscular dystrophy patients, where dystrophin itself is absent or greatly reduced. The expression of DMDL protein is not restricted to smooth and skeletal muscle, however, since relatively large amounts are present in transformed brain cell lines of both glial and Schwann cell origin. This contrasts with the low levels of DMDL protein in adult brain tissue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757469      PMCID: PMC2289198          DOI: 10.1083/jcb.115.6.1695

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  15 in total

Review 1.  Control of acetylcholine receptors in skeletal muscle.

Authors:  D M Fambrough
Journal:  Physiol Rev       Date:  1979-01       Impact factor: 37.312

2.  Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

Authors:  E P Hoffman; R H Brown; L M Kunkel
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

3.  Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse.

Authors:  D R Love; G E Morris; J M Ellis; U Fairbrother; R F Marsden; J F Bloomfield; Y H Edwards; C P Slater; D J Parry; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Identification of a chromosome 6-encoded dystrophin-related protein.

Authors:  T S Khurana; E P Hoffman; L M Kunkel
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

5.  Monoclonal antibody evidence for structural similarities between the central rod regions of actinin and dystrophin.

Authors:  T M Nguyen; J M Ellis; I B Ginjaar; M M van Paassen; G J van Ommen; A F Moorman; A J Cartwright; G E Morris
Journal:  FEBS Lett       Date:  1990-10-15       Impact factor: 4.124

6.  A homologue of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice. Immunological evidence.

Authors:  F Pons; N Augier; J O Léger; A Robert; F M Tomé; M Fardeau; T Voit; L V Nicholson; D Mornet; J J Léger
Journal:  FEBS Lett       Date:  1991-04-22       Impact factor: 4.124

7.  An autosomal transcript in skeletal muscle with homology to dystrophin.

Authors:  D R Love; D F Hill; G Dickson; N K Spurr; B C Byth; R F Marsden; F S Walsh; Y H Edwards; K E Davies
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

8.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein.

Authors:  M Koenig; A P Monaco; L M Kunkel
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

9.  Transfection of neonatal rat Schwann cells with SV-40 large T antigen gene under control of the metallothionein promoter.

Authors:  G I Tennekoon; J Yoshino; K W Peden; J Bigbee; J L Rutkowski; Y Kishimoto; G H DeVries; G M McKhann
Journal:  J Cell Biol       Date:  1987-11       Impact factor: 10.539

10.  Expression of several adhesive macromolecules (N-CAM, L1, J1, NILE, uvomorulin, laminin, fibronectin, and a heparan sulfate proteoglycan) in embryonic, adult, and denervated adult skeletal muscle.

Authors:  J R Sanes; M Schachner; J Covault
Journal:  J Cell Biol       Date:  1986-02       Impact factor: 10.539

View more
  71 in total

1.  Monoclonal antibodies for dystrophin analysis. Epitope mapping and improved binding to SDS-treated muscle sections.

Authors:  T M Nguyen; I B Ginjaar; G J van Ommen; G E Morris
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

2.  Report of ENMC workshop on the limb-girdle muscular dystrophies.

Authors:  A Clarke
Journal:  J Med Genet       Date:  1992-10       Impact factor: 6.318

Review 3.  Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials.

Authors:  Yuko Shimizu-Motohashi; Shouta Miyatake; Hirofumi Komaki; Shin'ichi Takeda; Yoshitsugu Aoki
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

4.  Effect of beta-dystroglycan processing on utrophin/Dp116 anchorage in normal and mdx mouse Schwann cell membrane.

Authors:  K Hnia; G Hugon; A Masmoudi; J Mercier; F Rivier; D Mornet
Journal:  Neuroscience       Date:  2006-06-02       Impact factor: 3.590

Review 5.  Progress in gene therapy of dystrophic heart disease.

Authors:  Y Lai; D Duan
Journal:  Gene Ther       Date:  2012-02-09       Impact factor: 5.250

6.  Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.

Authors:  Pilar Martínez-Martínez; Mario Losen; Hans Duimel; Peter Frederik; Frank Spaans; Peter Molenaar; Angela Vincent; Marc H De Baets
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 7.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

8.  Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle.

Authors:  D J Law; J G Tidball
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

Review 9.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

10.  Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.

Authors:  T M Nguyen; G E Morris
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.